Know the compound.
Read the evidence.
Twenty-five detailed research guides, written to make complex mechanisms readable without flattening the science. Compare pathways, inspect the evidence and understand the laboratory variables behind each compound.

Reading the evidence
Not all findings carry the same weight.
Established & clinical
Human trials offer stronger evidence, within the limits of each studied population, preparation and endpoint.
Early human
Small or regional studies can establish biological activity without settling efficacy or long-term safety.
Preclinical & blends
Cell, animal and constituent evidence explains a rationale; it does not prove an outcome in humans.
The complete index
Compound library
AOD9604
Modified C-terminal fragment of human growth hormone researched for lipolysis and fat metabolism.
BPC-157
Body Protection Compound. Researched for tissue repair, gut health and connective-tissue recovery.
BPC-157 / TB-500
Pre-mixed BPC-157 and TB500 blend researched for synergistic soft-tissue and connective recovery.
Cagrilintide
Long-acting amylin analogue researched for appetite suppression, satiety and adjunctive weight-management protocols.
CJC-1295 / Ipamorelin
Synergistic GHRH + GHRP blend studied for pulsatile endogenous GH support.
DSIP
Delta Sleep-Inducing Peptide researched for slow-wave sleep architecture and stress modulation.
Epitalon
Synthetic pineal tetrapeptide researched for telomerase activation, circadian regulation and longevity biomarkers.
GHK-Cu
Copper-binding tripeptide researched for collagen synthesis, skin remodelling and hair density.
GLOW
Triple-peptide blend of BPC-157, GHK-Cu and TB500 researched for skin, hair and connective-tissue regeneration.
Glutathione
Master endogenous tripeptide antioxidant researched for oxidative stress, detoxification, immune support and skin brightening.
Ipamorelin
Selective ghrelin/GHS-R1a agonist researched for clean pulsatile GH release with minimal cortisol or prolactin impact.
KLOW
Multi-peptide blend (GHK-Cu / Larazotide / Orexin-A / KPV) researched for skin, gut and regenerative protocols.
KPV
Alpha-MSH C-terminal tripeptide researched for anti-inflammatory and gut-mucosal repair applications.
Melanotan II
Synthetic melanocortin receptor agonist researched for melanogenesis, photoprotection and appetite modulation.
MOTS-c
Mitochondrial-derived peptide researched for metabolic health, insulin sensitivity and exercise capacity.
NAD+
Nicotinamide Adenine Dinucleotide researched for cellular energy, sirtuin activity and longevity protocols.
Retatrutide
Investigational triple GIP / GLP-1 / Glucagon receptor agonist with class-leading weight-loss data.
Selank
Synthetic heptapeptide researched for anxiolytic effects, BDNF expression and cognitive performance.
Semaglutide
Long-acting GLP-1 receptor agonist researched for weight, glycaemic and cardiometabolic outcomes.
Semax
ACTH-fragment analogue researched for neuroprotection, focus and BDNF/NGF upregulation.
SS-31
Mitochondrial-targeted tetrapeptide (Elamipretide) researched for cardiolipin stabilisation, cellular energy and age-related mitochondrial decline.
TB-500
Thymosin Beta-4 active fragment. Researched for soft-tissue repair, angiogenesis and mobility.
Tesamorelin
Stabilised GHRH analogue researched for visceral adipose reduction and lean mass support.
Thymosin Alpha-1
Immunomodulatory peptide researched for immune support, vaccine adjuvant activity and viral defence protocols.
Tirzepatide
Dual GIP / GLP-1 receptor agonist with class-leading weight and glycaemic outcomes (SURMOUNT / SURPASS).
From reference to calculation
Already reading a compound guide?
Each field note links to the calculator with that compound preselected, so the research context stays close to the maths.